Pathol. Oncol. Res. Pathology & Oncology Research Pathol. Oncol. Res. 1532-2807 Frontiers Media S.A. 1610989 10.3389/pore.2023.1610989 Pathology and Oncology Archive Correction Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma Ma et al. 10.3389/pore.2023.1610989 Ma Yu-Ting 1 ‡ Li Yan 2 ‡ Yan Li 3 ‡ Hua Fang 4 Wang Dong-Guan 3 Xu Guo-Ying 5 Yang Hong-Lan 2 Xue Ying-Jie 1 Qin Ye-Jun 1 Sha Dan 6 Ning Hao 7 Zhao Miao-Qing 8 * Yao Zhi-Gang 1 * † 1 Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China 2 Departmentof Oncology, Dongying City People’s Hospital, Dongying, China 3 Department of Pathology, Dongying City People’s Hospital, Dongying, China 4 Department of Microbiology and Immunology, Tulane University, New Orleans, LA, United States 5 Department of Urology Surgery, Dongying Hospital of Traditional Chinese Medicine, Dongying, China 6 Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China 7 Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China 8 Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China

Edited by: Pathology & Oncology Research Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Zhi-Gang Yao, yzg20062009@163.com; Miao-Qing Zhao, zhaomqsd@163.com

ORCID: Zhi-Gang Yao, orcid.org/0000-0002-8034-6524

These authors have contributed equally to this work

 30 01 2023 2023 29 1610989 04 12 2022 12 01 2023 Copyright © 2023 Ma, Li, Yan, Hua, Wang, Xu, Yang, Xue, Qin, Sha, Ning, Zhao and Yao. 2023 Ma, Li, Yan, Hua, Wang, Xu, Yang, Xue, Qin, Sha, Ning, Zhao and Yao

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma by Ma Y-T, Li Y, Yan L, Hua F, Wang D-G, Xu G-Y, Yang H-L, Xue Y-J, Qin Y-J, Sha D, Ning H, Zhao M-Q and Yao Z-G (2022). Pathol Oncol Res. 28:1610638. doi: 10.3389/pore.2022.1610638 immunotherapy microsatellite instability immune checkpoint inhibitors urothelial carcinoma lynch syndrome PD-1/PD-L1

In the published article there was an error in the author list. Authors Hong-Lan Yang and Yan Li were listed in the wrong order. The equal contribution of the first co-authors was not included. The corrected author list appears below:

Yu-Ting Ma1‡, Yan Li2‡, Li Yan3‡, Fang Hua4, Dong-Guan Wang3, Guo-Ying Xu5, Hong-Lan Yang2, Ying-Jie Xue1, Ye-Jun Qin1, Dan Sha6, Hao Ning7, Miao-Qing Zhao8* and Zhi-Gang Yao1*†

†ORCID: Zhi-Gang Yao, orcid.org/0000-0002-8034-6524

‡Contributed equally to this work

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.